Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.

View/Open
Volume
4
Pagination
e463 - ?
DOI
10.1097/HS9.0000000000000463
Journal
Hemasphere
Issue
5
Metadata
Show full item record
Abstract
Supplemental Digital Content is available in the text.
Authors
Deshantri, AK; Fens, MHAM; Ruiter, RWJ; Metselaar, JM; Storm, G; Mandhane, SN; Graat, GHM; Lentjes, EGW; Yuan, H; de Bruijn, JD
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67305
Collections
Language
eng
Licence information
This is an open access article distributed under the terms of the Creative Commons Attribution- NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Attribution-NonCommercial-ShareAlike 3.0 United States
Copyright statements
© 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

The following license files are associated with this item:

This is an open access article distributed under the terms of the Creative Commons Attribution- NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Except where otherwise noted, this item's license is described as This is an open access article distributed under the terms of the Creative Commons Attribution- NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.